Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Lesion”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Testing effectiveness (Phase 2)Study completedNCT00333138
What this trial is testing

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis 281
Testing effectiveness (Phase 2)WithdrawnNCT00104143
What this trial is testing

A4I Antagonist in Patients With Relapsing Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche
Not applicableLooking for participantsNCT06955832
What this trial is testing

Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI

Who this might be right for
Multiple Sclerosis
Benha University 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05156281
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,011
Not applicableStudy completedNCT04220814
What this trial is testing

Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Rennes University Hospital 94
Testing effectiveness (Phase 2)Study completedNCT01772199
What this trial is testing

Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 131
Not applicableStudy completedNCT00094068
What this trial is testing

The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
National Institutes of Health Clinical Center (CC) 76
Not applicableStudy completedNCT05426980
What this trial is testing

Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study

Who this might be right for
Multiple SclerosisMultiple Sclerosis LesionMultiple Sclerosis Brain Lesion
University of Ljubljana 654
Not applicableUnknownNCT05123443
What this trial is testing

Longitudinal Assessment of Iron Rims in MS Lesions

Who this might be right for
Multiple Sclerosis
Nottingham University Hospitals NHS Trust 100
Not applicableLooking for participantsNCT06827834
What this trial is testing

Spinal Cord Monitoring in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Zuyderland Medisch Centrum 155
Not applicableLooking for participantsNCT05227092
What this trial is testing

3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)

Who this might be right for
Multiple Sclerosis
University Hospital, Bordeaux 60
Not applicableStudy completedNCT00937157
What this trial is testing

Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)

Who this might be right for
Multiple Sclerosis
University at Buffalo 12
Not applicableEnded earlyNCT02896647
What this trial is testing

3D Phase Sensitive Inversion Recuperation MRI to Detect and Characterize Multiple Sclerosis Spinal Cord Lesions

Who this might be right for
Multiple Sclerosis
Fondation Ophtalmologique Adolphe de Rothschild 60
Large-scale testing (Phase 3)Study completedNCT03140449
What this trial is testing

Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

Who this might be right for
Facial Angiofibroma
National Taiwan University Hospital 52
Large-scale testing (Phase 3)Study completedNCT00799890
What this trial is testing

Sunphenon in Progressive Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Friedemann Paul 61
Large-scale testing (Phase 3)Study completedNCT05495425
What this trial is testing

Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

Who this might be right for
Tuberous Sclerosis Complex
Nobelpharma 43
Not applicableLooking for participantsNCT05776511
What this trial is testing

Diagnostic Value of eVOG

Who this might be right for
Multiple SclerosisRadiologically Isolated SyndromeWhite Matter Lesions
Centre Hospitalier Universitaire de Nice 150
Not applicableUnknownNCT05482906
What this trial is testing

Common and Specific Information From Neuroimaging and Smartphone

Who this might be right for
Multiple Sclerosis
Nantes University Hospital 100
Large-scale testing (Phase 3)Study completedNCT02792231
What this trial is testing

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

Who this might be right for
Relapsing Multiple Scelrosis
Novartis Pharmaceuticals 955
Testing effectiveness (Phase 2)Study completedNCT00676715
What this trial is testing

The Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genentech, Inc. 220
Load More Results